Area of research
Molecular Biology · Genetics
Research interest
Research focused on Mesenchymal stem cell and Protein phosphatase 2, with related work in Cell biology, Myocardial infarction, Antagomir. Notable publications include 'Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice', 'The stem cell factor/Kit signalling pathway regulates mitochondrial function and energy expenditure', and 'Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model'.
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism
Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model
The enhanced effect and underlying mechanisms of mesenchymal stem cells with IL-33 overexpression on myocardial infarction
Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice
Protein phosphatase 2A regulatory subunit B56β modulates erythroid differentiation
Protein phosphatase 2A plays an important role in migration of bone marrow stroma cells
The stem cell factor/Kit signalling pathway regulates mitochondrial function and energy expenditure